The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Graf Acquisition Partners Iv Llc since 2023.
This trader's CIK number is 1862622.
At the time of last reporting, Graf Acquisition Partners Iv Llc was the 10% Owner of Nkgen Biotech, Inc.. (stock ticker symbol NKGN).
Also see all insider trading activities at Nkgen Biotech, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | NKGN | 693 | $2,238 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-12-01 | NKGN | Buy | 220 | 3.35 | 737 |
| 2023-12-04 | NKGN | Buy | 450 | 3.19 | 1,435 |
| 2023-11-21 | NKGN | Buy | 13 | 2.92 | 37 |
| 2023-11-20 | NKGN | Buy | 10 | 2.94 | 29 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Graf Acquisition Partners Iv Llc (10% Owner of Nkgen Biotech, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.